Sleep Apnea Devices market is expected to reach US$ 12.23 billion by 2033 from US$ 6.47 billion in 2024, with a CAGR of 7.32% from 2025 to 2033 reports Research and Markets.
Among other contributing reasons, the growing prevalence of sleep apnea and associated comorbidities, growing awareness of sleep apnea and sleep disorders, and the aging population’s increased need are all responsible for the market’s strong rise.
Sleep Apnea Devices Industry Overview
Because of the rising incidence of sleep apnea diseases, especially obstructive sleep apnea (OSA), and increased awareness of the problem, the market for sleep apnea devices is expanding significantly. Millions of individuals worldwide suffer from sleep apnea, and as more people become aware of the health dangers it poses, including those to diabetes, stroke, and cardiovascular disease, there is a growing need for efficient treatment options.
Technological advancements that improve patient management and therapy customization, like mobile apps for sleep monitoring, connected devices, and portable home sleep testing, are driving the market. Increased accessibility and uptake have also been facilitated by the growth of e-commerce platforms and the expanding availability of sleep apnea devices in home healthcare settings.
Notwithstanding these encouraging developments, the business still confronts obstacles such as the high expense of care, restricted insurance coverage in some areas, and problems with device adherence brought on by discomfort or loudness. However, in the upcoming years, the market is anticipated to continue expanding due to the rising demand for home-based therapies and rising healthcare expenditures on sleep apnea treatment.
Growth Drivers for the Sleep Apnea Devices Market
Increasing Patient Adoption of Cutting-Edge Sleep Apnea Management Devices
The development of new options for managing sleep apnea has been greatly aided by the growing preference for technologically sophisticated gadgets. Among other things, patient comfort is one of the reasons why oral devices like the mandibular advancement device (MAD) are becoming more and more popular for treating OSA. Additionally, as the market grows, major manufacturers are introducing novel oral appliances that have been shown to be successful and provide patients with comfort while they treat the condition.
To meet the increasing needs of patients with obstructive sleep apnea (OSA), the U.S. FDA, for example, approved a novel mandibular repositioning device called AIO BREATHE in February 2024. This and the actometer, a portable diagnostic tool, are both becoming more and more popular for a variety of reasons, such as their affordability and non-invasiveness. Thus, the increasing need for affordable sleep apnea diagnostic tools is supporting patients’ preference for actometers and oral appliances for successful sleep apnea treatment.
Growing Obstructive Sleep Apnea Prevalence Will Increase Device Demand
increasing rates of obstructive sleep apnea in patients as a result of a number of causes, such as obesity, high levels of stress, poor sleep habits, and sedentary lifestyles. An estimated 39 million adults in the United States suffer with obstructive sleep apnea, according to a 2023 article published by the National Council on Aging (NCOA).
For example, according to the American Heart Association article, multiple cross-sectional studies have suggested that 70% of OSA patients are fat, and 40% of the obese population has substantial sleep apnea. Additionally, data from the European Respiratory Society showed that between 13.0% and 32.0% of Europe’s elderly population had sleep apnea.
Patients are receiving more treatment as a result of the expanding diagnosis rate, which is further supported by the rising prevalence of obesity and other lifestyle disorders as well as rising healthcare costs. This is contributing to the increasing market uptake of these devices, as does the expansion of sleep clinics and technicians. Another element anticipated to support market expansion is the expansion of strategic initiatives and educational activities aimed at boosting public knowledge of the situation.
Increasing Awareness and Diagnosis
The market is expanding due in large part to rising awareness and diagnosis of sleep apnea. The need for sleep apnea diagnosis and treatment is rising as more people become aware of the dangers of untreated sleep apnea, including heart disease, diabetes, and stroke. Media coverage, healthcare professional education, and public awareness initiatives have all been crucial in educating people about the value of early detection.
Patients are finding it easier to receive a diagnosis because to improved diagnostic techniques such sophisticated polysomnography and at-home sleep studies. More people are seeking evaluation as global healthcare systems increase their emphasis on sleep health, which raises the diagnostic rate. The market for sleep apnea devices is developing as a result of the increased awareness of the problem, which is de-stigmatizing it and promoting early therapies.
Challenges in the Sleep Apnea Devices Market
Patient Compliance and Adherence
With CPAP therapy, the most popular treatment for obstructive sleep apnea, patient compliance and adherence continue to be major obstacles in the market for sleep apnea devices. Because of discomfort, noise, air pressure, and mask fit difficulties, many patients find it difficult to use their devices on a regular basis. Low adherence rates brought on by these obstacles may lessen the efficacy of treatment and perhaps harm health consequences.
Because of this, many people stop taking their medication even if it has been shown to be beneficial, which raises their chance of developing heart disease, stroke, and other problems. Manufacturers are concentrating on creating devices that are more comfortable, quiet, and easy to use in order to increase compliance. Furthermore, adherence can be improved by patient education, ongoing monitoring, and support via telemedicine and mobile apps, which will help patients better manage their conditions over the long run.
Competition from Alternative Therapies
The market for sleep apnea equipment is challenged by competition from alternative therapies. Even though CPAP therapy is still the most effective treatment for obstructive sleep apnea, many patients look for alternatives because they are uncomfortable or inconvenient. Patients who cannot tolerate CPAP may find oral appliances, such as mandibular advancement devices (MADs), to be an appealing alternative because they provide a non-invasive treatment for mild to moderate instances of sleep apnea.
Positional therapy, which promotes specific sleeping positions for patients in order to avoid airway blockage, is also becoming more and more well-liked. Surgical procedures such as uvulopalatopharyngoplasty (UPPP) or surgically implanted devices like Inspire treatment are also taken into consideration in extreme circumstances. Traditional sleep apnea devices face competition from these alternatives as they gain popularity and efficacy, which restricts market expansion and forces producers to develop new products.
Company Analysis: Overview, Recent Developments, Financial Insights
Carefusion Corp
Somnomed
ResMed Inc.
Koninklijke Philips N.V.
Compumedics Limited (CMP)
Nihon Kohden Corporation
Natus Medical Incorporated
Teleflex Incorporated
Key Attributes:
Report Attribute Details
No. of Pages 190
Forecast Period 2024 – 2033
Estimated Market Value (USD) in 2024 $6.47 Billion
Forecasted Market Value (USD) by 2033 $12.23 Billion
Compound Annual Growth Rate 7.3%
Regions Covered Global
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges
5. Global Sleep Apnea Devices Market
6. Market Share
6.1 By Products Types
6.1.1 By Therapeutics
6.1.2 By Diagnostics
6.2 By End User
6.3 By Countries
7. Product Types
7.1 Therapeutic Devices
7.1.1 CPAP Sleep Apnea Therapeutic Devices
7.1.2 Auto CPAP Sleep Apnea Therapeutic Devices
7.1.3 BiPAP Sleep Apnea Therapeutic Devices
7.1.4 Adaptive Servo-Ventilation (ASV)
7.2 Diagnostic Devices
7.2.1 Polysomnography Devices (PSG)
7.2.2 Oximeter
7.2.3 Actigraphy Monitoring Device
7.2.4 Respiratory Polygraph
7.2.5 Sleep Apnea Screening Device
8. End User
8.1 Sleep Laboratories, Clinics & Hospitals
8.2 Home Care Settings/Individuals
9. Countries
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Switzerland
9.3 Asia – Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 South Korea
9.3.5 Indonesia
9.3.6 Australia
9.4 Latin America
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
9.5 Middle East & Africa
9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 United Arab Emirates
9.6 Rest of World
10. Porter’s Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threats
12. Key Players Analysis
For more information about this report visit here.